Suppr超能文献

MRI 监测下经导管动脉内递送超顺磁性氧化铁标记的自然杀伤细胞治疗肝细胞癌:在啮齿动物模型中的临床前研究。

MRI-monitored transcatheter intra-arterial delivery of SPIO-labeled natural killer cells to hepatocellular carcinoma: preclinical studies in a rodent model.

机构信息

Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

出版信息

Invest Radiol. 2013 Jun;48(6):492-9. doi: 10.1097/RLI.0b013e31827994e5.

Abstract

OBJECTIVES

The objective of this study was to test the hypotheses that intra-arterial infusion allows for targeted natural killer (NK) lymphocyte delivery to hepatocellular carcinoma (HCC) and that iron oxide labeling allows for quantitative visualization of intra-arterial NK delivery with magnetic resonance imaging (MRI).

MATERIALS AND METHODS

Experiments received approval from the institutional animal care and use committee. NK-92MI cells were labeled with superparamagnetic iron oxide (SPIO) nanoparticles. Cell viability, labeling efficacy, and cell phantom imaging studies were performed. Eighteen rats were each implanted with HCC tumors. Catheter was placed in proper hepatic artery for either NK lymphocyte (12 rats) or saline (6 rats) infusion. For the 6 rats, MRI T2* measurements for tumor and normal liver were compared before and after the NK infusion and correlated with histologic measurements. Prussian blue staining was used for labeled NK identification. The remaining rats survived for 8 days after the infusion to compare tumor size changes in the rats that received NK cell (6 rats) or saline (6 rats) infusions. Spearman correlation coefficients and t tests were calculated for statistical analyses.

RESULTS

Increasing SPIO incubation concentration decreased cell viability. Labeling efficacy mean (SD) was 88.0% (3.1%) across samples. The spatial extent of T2*-weighted contrast and R2* relaxivity values increased for cell phantom samples incubated with increasing SPIO concentrations. T2* measurements decreased in the tumor and normal liver tissues after the NK infusion (P < 0.001); ΔT2* was greater in the tumors than in the normal liver tissue (P < 0.001). Histologic measurements demonstrated increased NK delivery to the tumor compared with the normal liver (P < 0.001). ΔT2* was well correlated with histologic NK measurements (ρ = 0.70). Changes in tumor diameter 8 days after the infusion were significantly different between those rats that received NK cell infusions (-2.49 [0.86] mm) and those that received sham saline infusion (5.23 [0.66] mm).

CONCLUSIONS

Intra-arterial infusion permitted selective delivery of NK cells to HCC. Transcatheter delivery of SPIO-labeled NK cells can be quantitatively visualized with MRI. Transcatheter NK cell delivery limited tumor size progression compared with controls.

摘要

目的

本研究旨在验证以下假设,即动脉内输注可实现对肝癌(HCC)的靶向自然杀伤(NK)淋巴细胞递送,并且氧化铁标记可允许通过磁共振成像(MRI)定量可视化动脉内 NK 递呈。

材料和方法

实验获得了机构动物护理和使用委员会的批准。将 NK-92MI 细胞用超顺磁氧化铁(SPIO)纳米颗粒标记。进行了细胞活力、标记效率和细胞体模成像研究。将 18 只大鼠分别植入 HCC 肿瘤。导管置于肝固有动脉内,用于 NK 淋巴细胞输注(12 只大鼠)或生理盐水输注(6 只大鼠)。对于 6 只大鼠,在 NK 输注前后比较肿瘤和正常肝脏的 MRI T2*测量值,并与组织学测量值相关联。普鲁士蓝染色用于鉴定标记的 NK。输注后,剩余的大鼠存活 8 天,以比较接受 NK 细胞(6 只大鼠)或生理盐水(6 只大鼠)输注的大鼠的肿瘤大小变化。计算 Spearman 相关系数和 t 检验进行统计分析。

结果

增加 SPIO 孵育浓度会降低细胞活力。标记效率平均值(SD)为 88.0%(3.1%)。随着 SPIO 浓度的增加,细胞体模样本的 T2*-加权对比和 R2弛豫率值的空间范围增加。NK 输注后,肿瘤和正常肝组织中的 T2测量值降低(P<0.001);与正常肝组织相比,肿瘤中的 ΔT2更高(P<0.001)。组织学测量显示,与正常肝组织相比,肿瘤中 NK 的递送增加(P<0.001)。ΔT2与组织学 NK 测量值具有良好的相关性(ρ=0.70)。输注后 8 天,接受 NK 细胞输注的大鼠(-2.49[0.86]mm)与接受假盐水输注的大鼠(5.23[0.66]mm)之间的肿瘤直径变化差异具有统计学意义。

结论

经动脉内输注可实现 NK 细胞对 HCC 的选择性递呈。经导管输送 SPIO 标记的 NK 细胞可通过 MRI 进行定量可视化。与对照组相比,经导管 NK 细胞输送可限制肿瘤大小的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e6f/3644319/33d842b8f6f7/nihms-454483-f0001.jpg

相似文献

引用本文的文献

2
Advances in NK cell therapy for brain tumors.脑肿瘤自然杀伤细胞疗法的进展。
NPJ Precis Oncol. 2023 Feb 15;7(1):17. doi: 10.1038/s41698-023-00356-1.
5
Nanotechnology synergized immunoengineering for cancer.纳米技术协同免疫工程治疗癌症。
Eur J Pharm Biopharm. 2021 Jun;163:72-101. doi: 10.1016/j.ejpb.2021.03.010. Epub 2021 Mar 24.
9
The Molecular Imaging of Natural Killer Cells.自然杀伤细胞的分子成像
Mol Imaging. 2018 Jan-Dec;17:1536012118794816. doi: 10.1177/1536012118794816.

本文引用的文献

3
Intra-arterial therapies for hepatocellular carcinoma: where do we stand?经动脉治疗肝细胞癌:我们处于什么位置?
Ann Surg Oncol. 2010 May;17(5):1234-46. doi: 10.1245/s10434-010-0977-4. Epub 2010 Apr 20.
5
Review article: the management of hepatocellular carcinoma.综述文章:肝细胞癌的治疗。
Aliment Pharmacol Ther. 2010 Feb 15;31(4):461-76. doi: 10.1111/j.1365-2036.2009.04200.x. Epub 2009 Nov 19.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验